BrightView stock draws mixed analyst ratings at USD 10.30

Published on 10/05/2026 at 21:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

BrightView stock was last at USD 10.30 on October 5, 2026, with a USD 960.4 million market cap. Q3 FY2026 revenue rose 1.3 percent to USD 717.6 million.

BV, US10948C1071, Illustration mit AI erstellt.

BrightView Holdings stock (ISIN US10948C1071) was last at USD 10.30 on the NYSE on October 5, 2026, at 3:36 p.m. ET, with a market capitalization of USD 960.4 million. The price was up USD 0.03, or 0.24 percent, from the prior close, while analyst assessments remain split between Buy and Hold.

Quarterly revenue edges higher

BrightView's latest reported quarter was Q3 fiscal 2026, ended June 30, 2026. According to MarketBeat on September 25, 2026, revenue reached USD 717.6 million, up 1.3 percent from the same quarter a year earlier.

The earnings comparison was less favorable. Adjusted EPS came in at USD 0.17 against a USD 0.29 consensus, a USD 0.12 shortfall, while the prior-year quarter produced USD 0.30 per share, according to MarketBeat.

Consensus splits over valuation

StockAnalysis lists a Buy consensus from 11 analysts and an average price target of USD 15.45. Against the USD 10.30 market price on October 5, 2026, that target stands USD 5.15 higher, or 50.0 percent above the price.

A separate compilation points to a more cautious reading. MarketBeat reported on September 25, 2026, that nine brokerages carried a Hold consensus with an average target of USD 14.10. The same report said Morgan Stanley had cut its target from USD 14.00 to USD 12.50 on August 6, 2026.

Stock remains below yearly high

BrightView's October 5, 2026 price of USD 10.30 sits USD 4.70 below the 52-week high of USD 15.00 and USD 0.49 above the 52-week low of USD 9.81. Trading volume stood at 573,116 shares, compared with an average volume of 1,055,176 shares.

The market is therefore weighing modest revenue growth against an earnings miss and a wide range of analyst expectations. For investors, the next test is whether operating improvement can narrow the gap between the latest quarterly profit and the forecasts embedded in the higher price targets.